Gene · 7507
Papers3,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma. | BMC Cancer | 2024 | 39237917 | PubTator, text mining | PubMed |
| Case report: Xeroderma pigmentosum Group A with erythropoietic protoporphyria in a young Chinese patient. | Front Endocrinol (Lausanne) | 2024 | 39129919 | PubTator, text mining | PubMed |
| Does the XPA-FEN1 Interaction Concern to Nucleotide Excision Repair or Beyond? | Biomolecules | 2024 | 39062528 | PubTator, text mining | PubMed |
| CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. | Cancers (Basel) | 2024 | 39001501 | PubTator, text mining | PubMed |
| Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study. | Chin J Cancer Res | 2024 | 38988482 | PubTator, text mining | PubMed |
| A diagnostic model for Parkinson's disease based on circadian rhythm-related genes. | J Transl Med | 2024 | 38978048 | PubTator, text mining | PubMed |
| A Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients. | Asian Pac J Cancer Prev | 2024 | 38918649 | PubTator, text mining | PubMed |
| Photosensitive Malar Rash in an Infant. | Indian Dermatol Online J | 2024 | 38845661 | PubTator, text mining | PubMed |
| Efficient Induction of Apoptosis in Lung Cancer Cells Using Bismuth Sulfide Nanoparticles. | Iran J Biotechnol | 2024 | 38827339 | PubTator, text mining | PubMed |
| Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure. | Nat Commun | 2024 | 38664429 | PubTator, text mining | PubMed |
| Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas. | Exp Eye Res | 2024 | 38641197 | PubTator, text mining | PubMed |
| Transcription-coupled DNA-protein crosslink repair by CSB and CRL4CSA-mediated degradation. | Nat Cell Biol | 2024 | 38600236 | PubTator, text mining | PubMed |
| Relationship between XPA, XPB/ERCC3, XPF/ERCC4, and XPG/ERCC5 Polymorphisms and the Susceptibility to Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. | Medicina (Kaunas) | 2024 | 38541204 | PubTator, text mining | PubMed |
| XPA tumor variant leads to defects in NER that sensitize cells to cisplatin. | NAR Cancer | 2024 | 38500596 | PubTator, text mining | PubMed |
| The REV-ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation. | Photochem Photobiol | 2024 | 38459721 | PubTator, text mining | PubMed |
| Generation of site-specifically labelled fluorescent human XPA to investigate DNA binding dynamics during nucleotide excision repair. | Methods | 2024 | 38387709 | PubTator, text mining | PubMed |
| Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction. | ChemMedChem | 2024 | 38300970 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. | Int J Mol Sci | 2024 | 38279330 | PubTator, text mining | PubMed |
| Unveiling Novel ERCC1-XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design. | Int J Mol Sci | 2024 | 38279246 | PubTator, text mining | PubMed |
| ERCC1 abundance is an indicator of DNA repair-apoptosis decision upon DNA damage. | Cell Death Discov | 2024 | 38272916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7507/papers?page=4